Verification services in Kanpur

During fertility treatment, eggs, sperm and embryos pass through several clinical and laboratory stages. Verification means checking that the people, reproductive material, instructions and records match at the relevant stage. Traceability means maintaining a documented link across those stages, including collection, processing, storage and use. These are safety processes within care rather than a treatment that changes an embryo. The phrase “embryo verification” can be unclear, so patients should ask exactly what is being checked and what information the check can establish.

A verification process may use identifying labels, records and witnessing procedures, but methods differ between centres. A witness check may involve another trained person or a validated electronic system; neither should be assumed to be available at PRAVI without confirmation. Ask how the clinic maintains identification when material is moved between containers or work areas. A useful explanation should describe the process in understandable terms, rather than relying only on references to technology or laboratory expertise.

Anyone undergoing IVF or ICSI can reasonably ask how identity checks are built into treatment. The discussion is especially relevant when using frozen eggs, sperm or embryos, because records must remain linked to stored material over time. It also matters when a patient changes their name, corrects demographic details or continues treatment at another centre. These circumstances do not necessarily indicate a problem, but they make clear documentation and communication particularly important before the next planned procedure.

Verification is not usually a separate procedure that patients need to undergo to improve their fertility. Someone seeking an explanation for unsuccessful implantation or repeated pregnancy loss will need clinical assessment rather than identity checks alone. Similarly, a person asking whether an embryo has a chromosome condition needs a different discussion about appropriate testing and its limitations. Where there is a specific discrepancy in records, the immediate priority is to clarify it with the responsible team, not to interpret it as evidence of embryo damage.

The initial review should establish whose treatment is being discussed, what material is involved and what action is planned. Relevant documents may include identity records, previous treatment summaries, storage information and signed consent forms. The clinic should explain its own requirements, including how it records identifiers and handles differences in spelling or other personal details. Bring discrepancies to the team’s attention early rather than assuming that matching names alone will be sufficient for every laboratory decision.

Consent and identity checks answer related but different questions. A correctly identified sample is not automatically authorised for every possible use. Instructions about fertilisation, storage, transfer, transport or disposal need to be reviewed within the applicable legal and clinical framework. If donor material is involved, current ART Act and Rules apply, with sourcing through registered ART banks as legally required. Ask how traceability is maintained while donor confidentiality is protected, and which information can lawfully be shared with you.

• Ask which documents must be provided before the planned procedure.
• Flag name changes, inconsistent identifiers or unclear consent instructions promptly.
• Confirm how corrected records remain linked to earlier treatment documentation.

Common points for identity verification include sperm collection, egg collection, preparation for IVF or ICSI, freezing, warming and embryo transfer. The precise sequence depends on the treatment and the laboratory’s procedures. At some stages, patients may be asked to confirm personal details directly. At other stages, checks take place within the laboratory. Ask which steps are witnessed, how a completed check is recorded and what happens if the information does not agree before work proceeds.

Before an embryo transfer, the discussion should distinguish identifying the intended embryo from deciding which embryo is clinically suitable to transfer. Embryo selection may consider development, appearance and other relevant clinical information; identification confirms its link to the treatment record. Verification itself does not improve embryo development. IVF or ICSI fertilisation does not guarantee implantation or live birth, and ICSI is not routinely better for everyone. Any recommendation for these treatments should be explained separately from the laboratory’s identity safeguards.

An identity check cannot establish whether an embryo is chromosomally typical, carries an inherited condition or will result in a healthy baby. It also cannot measure egg quality or explain every unsuccessful treatment cycle. Claims that verification produces higher IVF success need evidence and should not be assumed from the service name. Even a well-documented identification process has limitations: its effectiveness depends on accurate information, consistent implementation, appropriate training and a clear response when something appears wrong.

Genetic testing is a separate service with separate indications and consent. Tests previously called PGS or PGD are now generally described as PGT-A, PGT-M or PGT-SR, depending on their purpose. These tests are not proven to benefit everyone and may produce mosaic, false or inconclusive results. They do not remove the need for prenatal counselling and discussion of appropriate testing during pregnancy. Sex selection is not permitted. Do not interpret a verification record as a genetic report, or assume that PRAVI performs genetic testing in-house.

For frozen reproductive material, traceability needs to continue beyond the original treatment cycle. Patients can ask how their storage inventory is recorded, how changes are documented and how contact details and permissions are kept current. A storage record should be discussed in terms of what was stored and its documented status, not as a promise of future pregnancy. Some eggs or embryos may not survive freezing and warming; verification cannot prevent all biological loss or guarantee unchanged quality.

Moving material between centres requires coordination, appropriate consent and documentation that allows the receiving team to reconcile what arrives with what was expected. Ask who is responsible for arranging transport, how identification and handover are recorded, and how receipt is confirmed. Transport conditions and identity verification are separate issues, although both matter. Do not assume that a request for verification includes a transport service. If records from another centre are incomplete or inconsistent, further clarification may be needed before material can be accepted or used.

Identity verification alone does not require medicines, fasting, anaesthesia or physical recovery. Any preparation instructions relate to the accompanying procedure, such as egg collection or embryo transfer, and should come from your treating team. Before attending, organise the requested documents and note any questions about names, identifiers, stored material or permissions. Follow-up after verification usually concerns records and clarification, rather than a medical result. Ask what written information you can receive and how to request an explanation of unfamiliar terms.

If a label, document or verbal statement seems inconsistent, tell the team immediately and request clarification before the associated procedure continues. A discrepancy may be administrative, but it should not be dismissed without review. Ask who will investigate, what can be confirmed from existing records and when you should expect an update. Keep copies of relevant correspondence. Confidentiality also matters: sensitive reproductive information should be shared through the clinic’s authorised channels, with access and disclosure governed by consent and applicable law.

• State the exact discrepancy rather than guessing its cause.
• Ask whether the planned procedure needs to pause pending clarification.
• Request a clear explanation of the review and any documented correction.

At a PRAVI IVF consultation in Kanpur, begin by explaining whether you want information about routine safeguards or help with a specific record concern. Ask the team to confirm what “verification services” means in your proposed care, which stages it covers and whether any separate review is available. PRAVI has centres in Kanpur and New Delhi, but you should confirm where your treatment, laboratory work and storage would take place rather than assuming that arrangements are identical between locations.

Laboratory questions may be appropriate for the embryology team; Dr. Rit Shukla is PRAVI’s Chief Embryologist. Ask how you can obtain an explanation of the actual protocol, including witnessing methods, documentation and escalation of discrepancies. Do not assume a particular technology or staffing arrangement from that role alone. Before giving consent, you should understand what is being checked, what remains outside the scope of verification and whom to contact afterwards. The purpose of this conversation is informed participation in care, not a guarantee of an error-free process or pregnancy.